Cargando…
Pathophisiology of Sickle Cell Disease and New Drugs for the Treatment
a. agents which reduce or prevent sickle cell dehydration; b. agents which reduce sickle cell-endothelial adhesive events; c. nitric oxide (NO) or NO-related compounds; d. anti-oxidant agents. Correction of the abnormalities ranging from membrane cation transport pathways to red cell-endothelial adh...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Università Cattolica del Sacro Cuore
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033152/ https://www.ncbi.nlm.nih.gov/pubmed/21415994 http://dx.doi.org/10.4084/MJHID.2009.024 |